These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15219058)

  • 1. [Epidemiology and clinical effect against "beta-lactam antibiotic induced vancoymcin-resistant MRSA (BIVR)"].
    Hanaki H
    Jpn J Antibiot; 2004 Apr; 57(2):204-12. PubMed ID: 15219058
    [No Abstract]   [Full Text] [Related]  

  • 2. Method of detecting beta-lactam antibiotic induced vancomycin resistant MRSA (BIVR).
    Hanaki H; Yamaguchi Y; Nomura S; Haraga I; Nagayama A; Sunakawa K
    Int J Antimicrob Agents; 2004 Jan; 23(1):1-5. PubMed ID: 14732306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiological investigation of MRSA with antagonistic effects of beta-lactam antibiotic and vancomycin].
    Yamaguchi Y; Hanaki H; Barada K; Inamatu T; Sunakawa K
    Kansenshogaku Zasshi; 2003 Sep; 77(9):661-6. PubMed ID: 14574841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological investigation of beta-lactam antibiotic induced vancomycin-resistant MRSA from clinical isolated MRSA--comparison of detection rate of BIVR with or without CZX].
    Hososaka Y; Hanaki H; Hayashi I; Kamibeppu K; Sunakawa K
    Kansenshogaku Zasshi; 2004 Aug; 78(8):717-21. PubMed ID: 15478647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR).
    Hanaki H; Yamaguchi Y; Yanagisawa C; Uehara K; Matsui H; Yamaguchi Y; Hososaka Y; Barada K; Sakai F; Itabashi Y; Ikeda S; Atsuda K; Tanaka H; Inamatsu T; Nagayama A; Sunakawa K
    J Infect Chemother; 2005 Apr; 11(2):104-6. PubMed ID: 15856381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)].
    Yanagisawa C; Hanaki H; Oishi T; Uehara K; Yamaguchi Y; Matui H; Sunakawa K
    Jpn J Antibiot; 2005 Feb; 58(1):11-6. PubMed ID: 15847221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
    Hatano K; Yokota Y; Hanaki H; Sunakawa K
    Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA].
    Nagasawa Z; Nakashima Y; Oho M; Kusaba K; Manome I; Nagayama A
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):7-15. PubMed ID: 19583457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effects of vancomycin, teicoplanin, and ceftizoxime alone and in combination against murine systemic infection in mice caused by "beta-lactam antibiotic induced vancomycin-resistant MRSA"].
    Hanaki H; Hatano K; Yokota Y; Sunagawa K
    Kansenshogaku Zasshi; 2004 Mar; 78(3):290-2. PubMed ID: 15103915
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological investigation of "beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)"].
    Hanaki H; Yamaguchi Y
    Kansenshogaku Zasshi; 2003 Jul; 77(7):499-504. PubMed ID: 12931576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BIVR].
    Hanaki H
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():428-35. PubMed ID: 17455657
    [No Abstract]   [Full Text] [Related]  

  • 12. Nosocomial infection of beta-lactam antibiotic-induced vancomycin-resistant Staphylococcus aureus (BIVR).
    Hososaka Y; Hanaki H; Yanagisawa C; Yamaguchi Y; Matsui H; Nakae T; Iwata S; Hayashi I; Sunakawa K
    J Infect Chemother; 2006 Aug; 12(4):181-4. PubMed ID: 16944255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid depletion of free vancomycin in medium in the presence of beta-lactam antibiotics and growth restoration in Staphylococcus aureus strains with beta-lactam-induced vancomycin resistance.
    Yanagisawa C; Hanaki H; Matsui H; Ikeda S; Nakae T; Sunakawa K
    Antimicrob Agents Chemother; 2009 Jan; 53(1):63-8. PubMed ID: 18936187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved method of detection of beta-lactam antibiotic-induced VCM-resistant MRSA (BIVR).
    Hanaki H; Yamaguchi Y; Barata K; Sakai H; Sunakawa K
    Int J Antimicrob Agents; 2004 Mar; 23(3):311-3. PubMed ID: 15164976
    [No Abstract]   [Full Text] [Related]  

  • 15. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
    Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT
    Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin.
    Aritaka N; Hanaki H; Cui L; Hiramatsu K
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1292-4. PubMed ID: 11257050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
    Goldstein FW; Atoui R; Ben Ali A; Nguyen JC; Ly A; Kitzis MD
    Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011.
    Hanaki H; Cui L; Ikeda-Dantsuji Y; Nakae T; Honda J; Yanagihara K; Takesue Y; Matsumoto T; Sunakawa K; Kaku M; Tomono K; Fukuchi K; Kusachi S; Mikamo H; Takata T; Otsuka Y; Nagura O; Fujitani S; Aoki Y; Yamaguchi Y; Tateda K; Kadota J; Kohno S; Niki Y
    J Infect Chemother; 2014 Sep; 20(9):527-34. PubMed ID: 25066429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low level ß-lactamase production in methicillin-resistant staphylococcus aureus strains with ß-lactam antibiotics-induced vancomycin resistance.
    Hirao Y; Ikeda-Dantsuji Y; Matsui H; Yoshida M; Hori S; Sunakawa K; Nakae T; Hanaki H
    BMC Microbiol; 2012 May; 12():69. PubMed ID: 22568976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA)].
    Hanaki H; Inaba Y; Sasaki K; Hiramatsu K
    Jpn J Antibiot; 1998 Aug; 51(8):521-30. PubMed ID: 9836124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.